Kanabis kao etiološki čimbenik akutnog
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SAŽETAK 
Cilj ovoga prikaza slučaja dijafragmalnog defekta 
s kasnim kliničkim ispoljavanjem, u petogodišnjeg 
dečaka, jeste još jedan doprinos boljoj dijagnostici 
u pedijatrijskoj populaciji. Radiologu i pedijatrima 
rendgenološki i CT nalaz grudnog koša impono-
vao je kao sekvestracija pluća, dečjim hirurzima 
kao benigni teratom, a u toku operacije utvrđen 
je mišićni hemidijafragmalni defekt desne strane. 
Ovaj slučaj naglašava sledeće: retkost ispoljavanja 
dijafragmalne kile u dece starijeg uzrasta, značaj 
“naglašene” kliničke sumnje na osnovu održa-
vanja znakova blage respiratorne insuficijencije, 
potrebu za dopunskim radiološkim ispitivanjima i 
operacijom u cilju dijagnoze ove abnormalnosti i 
“uspešnost” prenatalne ultrazvučne dijagnostike. 
Ključne reči: dijafragmalne kile, oštećenje plu-
ća, starija deca, prenatalni ultrazvuk
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ABSTRACT
Acute pancreatitis is a common disease. Despite 
the frequent use of cannabis worldwide, only six 
reports have described cases of acute pancreatitis 
secondary to the use of tetrahydrocannabinoid 
(THC). Here we describe two cases of THC-in-
duced pancreatitis. The first case occurred in a 
38-year-old man with multiple admissions for 
THC-induced pancreatitis; the second case invol-
ved a 22-year-old man with no previous medical 
history. In both cases, other possible causes of 
acute pancreatitis were ruled out. 
Key words: common disease, tetrahydrocanna-
binoid, etiology
INTRODUCTION
Acute pancreatitis (AP) is an inflammatory disor-
der of the pancreas (1). In different parts of Euro-
pe, the annual AP incidence is 20 to 30 new cases 
per 100 000 population (1). Acute pancreatitis 
has many known causes, including gallstones, al-
cohol abuse, hypertriglyceridaemia, trauma, pan-
creatic malformations, infection, and drug use 
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(1). Drug-induced AP is relatively rare. A German 
study reported a 1.4% incidence of drug-induced 
AP (1). Drugs that cause AP include antibiotics 
(metronidazole), immunosuppressants (azathio-
prin), antihypertensives (angiotensin converting 
enzyme inhibitors, furosemide, or thiazide diure-
tics), aspirin, and valproic acid (1-3). Cannabis 
use can also cause AP, but only six patients have 
been described in the literature (4-7). Here we re-
port two patients with cannabis-induced AP.
CASE REPORT
Case 1
In December 2010, a 38-year-old man was admit-
ted to the Department of Gastroenterology, who 
complained of upper abdominal pain, nausea, and 
vomiting over the past 36 hours. The pain was de-
scribed as constant, sharp, aggravated by movement, 
propagated to the back, and between the scapulae. 
The patient history included multiple episodes of 
pancreatitis. He claimed that he did not drink al-
cohol, smoke, or take any chronic medications. He 
initially denied illicit drug use. Family history was 
insignificant (Table 1). The abdominal ultrasound 
was normal; however, follow-up high resolution 
multi-slice tomography (MSCT) scans revealed 
mild pancreatitis with no biliary disorders. After a 
diagnosis of tetrahydrocannabinol (THC)-induced 
pancreatitis was suspected, the patient admitted 
smoking THC for the previous three years. The pa-
tient records showed that, since 2008, the patient 
had been admitted to our department eight times, 
with similar symptoms, laboratory results, and 
imaging findings. However, no urine drug screen 
had been performed previously. He was advised to 
avoid THC, and he has not been admitted since. 
Case 2
In April 2008, a 22-year-old man was admitted to 
our department with a one-day history of sudden 
onset, severe abdominal pain, radiating to the back, 
with nausea, but no vomiting. He had no previous 
medical history. He did not smoke, drink alcohol, or 
take any chronic medications. There was no family 
history of similar abdominal problems. He initially 
denied illicit drug use (Table 1). An ultrasound 
examination of the abdomen showed no abnor-
malities. Abdominal computed tomography (CT) 
scan revealed a mild pancreatic swelling, but no 
evidence of gallstones or biliary tree dilatation/ob-
struction. A magnetic resonance cholangiopancrea-
tography (MRCP) confirmed the absence of biliary 
tree pathology and structural abnormalities in the 
pancreas. Initially, we treated the patient support-
ively, and his recovery began well. Seven days after 
the admission, the patient had a second episode of 
severe, worsening pain. He required sedation and 
epidural analgesia. Elevations were noted in serum 
amylase at 2277 U/L, lipase at 2574 U/L, and CRP 
at 52 mg/L (reference value 0 – 5.0 mg/L). When 
questioned, the patient denied intake of prohibited 
food or drugs, other than those prescribed. 
At 15 days after admission, he experienced a third 
attack of acute pain. Again, amylase and lipase 
levels were elevated, and CRP was 200 mg/L. A 
second CT scan revealed initial signs of pancreatic 
necrosis. After finding a positive THC urine drug 
screen, the patient finally admitted to smoking 
marijuana during hospitalization and the day be-
fore admission. He was strongly advised to avoid 
THC. He recovered well, and he was discharged 
from the hospital. For this patient, regular use of 
cannabis resulted in several hospitalizations with 
acute pancreatitis relapses. Finally, he developed 
chronic pancreatitis with pseudocyst formation. 
Because marijuana use is illegal, it is difficult to 
raise public awareness of its systemic effects (4,5). 
Thus, little clinical evidence is available showing 
a link between THC and systemic disorders (5-8). 
The exact mechanism by which THC causes AP 
remains unclear (4-7). Humans express two types 
Clinical measures Case 1 Case 2 Reference range
Heart rate (beats/min) 100 106 M
Blood pressure (systolic/
diastolic; mmHg) 150/80 140/75 M
Respiratory rate (breaths/
min) 20 20 M
Body temperature (°C) normal 37 M
Epigastric examination mild tenderness mild tenderness
Bowel movement decreased decreased
White blood cell count 
(×109/L) 13,4 9.2 3.4-9.7
Lipase (U/L) 150 220 13-60
Amylase (U/L) 400 800 23-91
Triglycerides (mmol/L) 1,3 1,12 <1.7
Serum calcium (mmol/L) 2.31 2.33 2.14-2.53
Infectious agents* negative negative
Alcohol negative negative
Urine tetrahydrocannabi-
nol (THC) positive positive
Table 1. Clinical characteristics of two patients with acute 
pancreatitis
*serum was tested for mumps virus, herpes simplex viruses 1 and 2, 
varicella zoster virus, cytomegalovirus, Epstein-Barr virus, HIV 1 
and 2, hepatitis A, B and C viruses, coxsackie virus, and echoviruses
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of cannabinoid receptors, known as CBI and CBII. 
Both receptors are expressed throughout the body; 
CBI is mostly expressed in the central and periphe-
ral nervous systems, endothelial cells, and vascular 
smooth muscle cells; CBII is expressed in macrop-
hages; and both CBI and CBII are expressed in the 
pancreas (8).  In the digestive system, cannabinoids 
have both beneficial and harmful effects (8,9). They 
inhibit gastric acid secretion, inhibit small intesti-
nal secretions, and delay gastric emptying (7-10). 
Dembínski et al (8), showed that these protective 
effects were achieved by activating CBI receptors 
in the stomach; there, CBI-receptor signalling ma-
intains gastric mucosal blood flow, promotes gastric 
mucosal DNA synthesis, and inhibits the release of 
interleukin-1β, an acute inflammatory mediator 
(8). However, in the pancreas, cannabinoids may 
have a harmful effect; mice with cerulein-induced 
pancreatitis showed increased severity when they 
received, anandamide, an endogenous cannabinoid 
receptor agonist. The exact mechanism for this ef-
fect remains unknown (6-11).
In our cases the AP was the most probably caused 
by THC. The first patient was advised to elude 
THC and has not been admitted since, while in 
the second case, the regular use of cannabis in 
our patient resulted in several hospitalizations for 
this patient because of acute pancreatitis relapses, 
which at last led to the development of chronic 
pancreatitis with pseudocyst formation. Also, it 
is important to emphasize that in almost 30% of 
cases, the etiology of AP is unknown, especially 
due to the unavailability of some methods, such 
as manometry of Odd’s sphincter and tests for 
IgG4 evaluation (1-6). 
Acute pancreatitis is a common disorder asso-
ciated with the use of marijuana. However, the 
exact mechanisms remain unknown and require 
further investigation. Because marijuana use has 
spread throughout the world, all patients with 
AP of unknown etiology should be carefully in-
vestigated for drugs that might contribute to the 
disease. This may be difficult, because patients 
are reluctant to admit using cannabis, due to its 
illegal status in most countries. 
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SAŽETAK 
Akutni pankreatitis (AP) je česta bolest. Unatoč 
raširenoj primjeni kanabisa diljem svijeta, prema 
dostupnoj literaturi do sada je prijavljeno samo 
šest slučajeva kanabisom izazvanog AP-a. U ovom 
radu prikazali smo dva slučaja akutnog pankreati-
tisa izazvanog tetrahidrokanabinolom (THC). Prvi 
slučaj zabilježen je kod 38-godišnjeg bolesnika s 
višestrukim hospitalizacijama zbog akutnog pan-
kreatitisa izazvanog THC-om, a u drugom slučaju 
radilo se o 22-godišnjaku bez prethodne povijesti 
Case report
